Axcella Health Inc.
AXLA
Price:
$4.58
Market Cap:
$0
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Mas...[Read more]
Industry
Biotechnology
IPO Date
2019-05-09
Stock Exchange
NASDAQ
Ticker
AXLA
The ROE as of September 2024 (TTM) for Axcella Health Inc. (AXLA) is -3582.11%
According to Axcella Health Inc.’s latest financial reports and current stock price. The company's current ROE is -3582.11%. This represents a change of 1.94% compared to the average of -175.92% of the last 4 quarters.
Axcella Health Inc. (AXLA) Historical ROE (quarterly & annually)
How has AXLA ROE performed in the past?
The mean historical ROE of Axcella Health Inc. over the last ten years is -418.05%. The current -3582.11% ROE has changed 756.86% with respect to the historical average. Over the past ten years (40 quarters), AXLA's ROE was at its highest in in the September 2022 quarter at 246.15%. The ROE was at its lowest in in the December 2022 quarter at -582.54%.
Average
-418.05%
Median
-88.80%
Minimum
-1977.98%
Maximum
26.59%
Axcella Health Inc. (AXLA) ROE by Quarter and Year
Discovering the peaks and valleys of Axcella Health Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 548.58%
Maximum Annual ROE = 26.59%
Minimum Annual Increase = -379.59%
Minimum Annual ROE = -1977.98%
| Year | ROE | Change |
|---|---|---|
| 2022 | -1977.98% | 548.58% |
| 2021 | -304.97% | 290.91% |
| 2020 | -78.02% | -21.66% |
| 2019 | -99.58% | 33.94% |
| 2018 | -74.35% | -379.59% |
Axcella Health Inc. (AXLA) Average ROE
How has AXLA ROE performed in the past?
The current ROE of Axcella Health Inc. (AXLA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-786.99%
5-year avg
-506.98%
10-year avg
-418.05%
Axcella Health Inc. (AXLA) ROE vs. Peers
How is AXLA’s ROE compared to its peers?
Axcella Health Inc.’s ROE is less than Cyclerion Therapeutics, Inc. (28.07%), greater than Magenta Therapeutics, Inc. (-61.71%), greater than Kezar Life Sciences, Inc. (-54.50%), less than ContraFect Corporation (403.13%), less than Panbela Therapeutics, Inc. (545.45%), less than CytomX Therapeutics, Inc. (-27.44%), less than Aridis Pharmaceuticals, Inc. (-21.32%), greater than Neoleukin Therapeutics, Inc. (-47.64%), greater than Assembly Biosciences, Inc. (-121.55%), greater than Instil Bio, Inc. (-55.57%), greater than Nuvation Bio Inc. (-98.79%), less than Akari Therapeutics, Plc (1.04%), greater than Salarius Pharmaceuticals, Inc. (-148.64%), greater than Histogen Inc. (-108.33%), greater than RenovoRx, Inc. (-403.38%), greater than Adial Pharmaceuticals, Inc. (-291.06%), less than Better Therapeutics, Inc. (223.92%), greater than Pasithea Therapeutics Corp. (-74.63%),
| Company | ROE | Market cap |
|---|---|---|
| 28.07% | $7.86M | |
| -61.71% | $42.44M | |
| -54.50% | $41.60M | |
| 403.13% | $1.72M | |
| 545.45% | $1.63M | |
| -27.44% | $95.30M | |
| -21.32% | $44.57K | |
| -47.64% | $8.20M | |
| -121.55% | $113.14M | |
| -55.57% | $422.75M | |
| -98.79% | $759.38M | |
| 1.04% | $41.66M | |
| -148.64% | $2.28M | |
| -108.33% | $929.11K | |
| -403.38% | $26.15M | |
| -291.06% | $7.17M | |
| 223.92% | $5.45K | |
| -74.63% | $4.04M |
Build a custom stock screener for Axcella Health Inc. (AXLA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Axcella Health Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Axcella Health Inc. (AXLA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Axcella Health Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Axcella Health Inc.'s ROE?
How is the ROE calculated for Axcella Health Inc. (AXLA)?
What is the highest ROE for Axcella Health Inc. (AXLA)?
What is the 3-year average ROE for Axcella Health Inc. (AXLA)?
What is the 5-year average ROE for Axcella Health Inc. (AXLA)?
How does the current ROE for Axcella Health Inc. (AXLA) compare to its historical average?